Artificial intelligence and machine learning algorithms for early detection of skin cancer in community and primary care settings: a systematic review.
View / Open Files
Authors
Jones, OT
Matin, RN
van der Schaar, M
Prathivadi Bhayankaram, K
Ranmuthu, CKI
Islam, MS
Behiyat, D
Boscott, R
Calanzani, N
Emery, J
Williams, HC
Walter, FM
Publication Date
2022-06Journal Title
Lancet Digit Health
ISSN
2589-7500
Publisher
Elsevier BV
Type
Article
This Version
AM
Metadata
Show full item recordCitation
Jones, O., Matin, R., van der Schaar, M., Prathivadi Bhayankaram, K., Ranmuthu, C., Islam, M., Behiyat, D., et al. (2022). Artificial intelligence and machine learning algorithms for early detection of skin cancer in community and primary care settings: a systematic review.. Lancet Digit Health https://doi.org/10.1016/S2589-7500(22)00023-1
Abstract
Skin cancers occur commonly worldwide. The prognosis and disease burden are highly dependent on the cancer type and disease stage at diagnosis. We systematically reviewed studies on artificial intelligence and machine learning (AI/ML) algorithms that aim to facilitate the early diagnosis of skin cancers, focusing on their application in primary and community care settings. We searched MEDLINE, Embase, Scopus, and Web of Science (from Jan 1, 2000, to Aug 9, 2021) for all studies providing evidence on applying AI/ML algorithms to the early diagnosis of skin cancer, including all study designs and languages. The primary outcome was diagnostic accuracy of the algorithms for skin cancers. The secondary outcomes included an overview of AI/ML methods, evaluation approaches, cost-effectiveness, and acceptability to patients and clinicians. We identified 14 224 studies. Only two studies used data from clinical settings with a low prevalence of skin cancers. We reported data from all 272 studies that could be relevant in primary care. The primary outcomes showed reasonable mean diagnostic accuracy for melanoma (89·5% [range 59·7-100%]), squamous cell carcinoma (85·3% [71·0-97·8%]), and basal cell carcinoma (87·6% [70·0-99·7%]). The secondary outcomes showed a heterogeneity of AI/ML methods and study designs, with high amounts of incomplete reporting (eg, patient demographics and methods of data collection). Few studies used data on populations with a low prevalence of skin cancers to train and test their algorithms; therefore, the widespread adoption into community and primary care practice cannot currently be recommended until efficacy in these populations is shown. We did not identify any health economic, patient, or clinician acceptability data for any of the included studies. We propose a methodological checklist for use in the development of new AI/ML algorithms to detect skin cancer, to facilitate their design, evaluation, and implementation.
Sponsorship
Cancer Research UK (23385)
Identifiers
External DOI: https://doi.org/10.1016/S2589-7500(22)00023-1
This record's URL: https://www.repository.cam.ac.uk/handle/1810/333734
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk